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Objective: Bone loss is typical in chronic inﬂammatory diseases such as rheumatoid arthritis, psoriasis,
ankylosing spondylitis, systemic lupus erythematosus, multiple sclerosis, inﬂammatory bowel diseases,
pemphigus vulgaris, and others. It is also typical in transplantation-related inﬂammation and during the
process of aging. While we recognized that bone loss is tightly linked to immune system activation or
inﬂamm-aging in the form of acute, chronic active, or chronic smoldering inﬂammation, bone loss is
typically discussed to be an “accident of inﬂammation.”
Methods: Extensive literature search in PubMed central.
Results: Using elements of evolutionary medicine, energy regulation, and neuroendocrine regulation of
homeostasis and immune function, we work out that bone waste is an adaptive, evolutionarily positively
selected program that is absolutely necessary during acute inﬂammation. However, when acute
inﬂammation enters a chronic state due to the inability to terminate inﬂammation (e.g., in autoimmunity
or in continuous immunity against microbes), the acute program of bone loss is a misguided adaptive
program.
Conclusions: The article highlights the complexity of interwoven pathways of osteopenia.
& 2015 The Authors. Published by Elsevier HS Journals, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In patients with chronic inﬂammatory diseases, there are three
major pillars that helped to explain debilitating and disabling
symptoms typical for these diseases such as sickness behavior,
anorexia, and many others (Table 1) [1]. These pillars are (1)
evolutionary medicine, (2) regulation of energy expenditure and
energy storage, and (3) neuroendocrine regulation of homeostasis
and immune function [1]. This manuscript presents an integrative
theory how the three pillars explain bone loss in the context of
acute and chronic inﬂammation.
The ﬁrst pillar uses elements of evolutionary medicine that
applies modern evolutionary theory to comprehend health and
disease. Thus, evolutionary medicine is non-teleological in nature.
It tries to understand why positively selected beneﬁcial adaptiver HS Journals, Inc. This is an open
che Forschungsgemeinschaft,
een supported by the Italian
d by grants from the National
028009).
.programs can promote modern diseases in contemporary individ-
uals [2]. For example, long-standing chronic inﬂammatory diseases
over months and years with a high energy demand did not exist
during most of our evolutionary time (including our primate and
non-primate ancestors) [3,4]. Thus, genes and molecular networks
have not been positively selected to serve long-standing, highly
energy-consuming, chronic inﬂammation.
Secondly, high energy expenditure in consumer organs such as
the immune system must happen in a transient manner during
short-lived diseases such as infection [1]. Long-standing energy
consumption as in chronic inﬂammatory diseases is incompatible
with long life [1]. Thus, mechanism of strong energy expenditure
were positively selected for short-lived highly energy-consuming
immune activation but not for long-standing, highly energy-
consuming chronic inﬂammatory diseases [1]. In contrast, energy
storage of nutrients in storage organs (e.g., adipose tissue),
immunoregulatory mechanisms, immune memory, and brain
memory have been positively selected to save energy.
Thirdly, neuronal and hormonal pathways are instrumental in
systemic regulation of energy expenditure and energy storage. In
addition, systemic neuroendocrine regulation shapes the immune
response and the immune response alters neuroendocrineaccess article under the CC BY-NC-ND license
Table 1
Sequelae of chronic inﬂammatory diseases in the light of altered energy regulation
Disease sequelae Pathophysiological elements in chronic inﬂammation leading to energy allocation to an activated immune system
Depressive symptoms/fatigue Cytokine (e.g., IL–1β)-driven sickness behavior and fatigue which increase time at rest (muscles and brain in an inactive
state)
Anorexia Consequence of sickness behavior
Malnutrition Consequence of anorexia and sickness behavior
Muscle wasting cachexia Protein break down in muscles as a consequence of anorexia, sickness behavior, IFG-1 resistance, and androgen deﬁcit
Cachectic obesity Protein break down in muscles as a consequence of anorexia and sickness behavior (protein break down greater than fat
break down)
Insulin (IGF-1) resistance (with
hyperinsulinemia)
Cytokine (e.g., TNF)-induced insulin signaling defects in liver, muscle, and fat tissue but not in immune cells. Immune
cells need insulin so that high insulin levels support the activity of the immune system (similar for IGF-1).
Dyslipidemiaa Cytokine driven acute phase reaction of lipid metabolism leading to higher delivery of cholesterol and other lipids to
macrophages
Increase of adipose tissue in the proximity
of inﬂammatory lesions
Presence of adipose tissue surrounding lymph nodes and in the proximity of inﬂammatory lesions reﬂects a local store of
energy-rich fuels (increased local estrogens might be important to drive local accumulation of adipose tissue).
Adipokines play a proinﬂammatory role.
Alterations of steroid hormone axes Cytokine/leptin-driven hypoandrogenemia supports muscle breakdown and protein delivery for gluconeogenesis and
support of an activated immune system (alanine, glutamine). Cortisol-to-androgen preponderance in chronic
inﬂammation is catabolic.
Elevated sympathetic tone and local
sympathetic nerve ﬁber loss
Cytokine-driven increase of SNS activity increases gluconeogenesis and lipolysis. The parallel loss of sympathetic nerve
ﬁbers in inﬂamed tissue supports local inﬂammation. It also stimulates lipolysis in the surrounding adipose tissue
because sympathetic nerve ﬁbers are increased there.
Hypertension Cytokine-driven activation of the water retention system due to systemic water loss during inﬂammation
Decreased parasympathetic tone Cytokine-driven decrease of the PSNS activity supports allocation of energy-rich fuels to an activated immune system.
References that demonstrate the respective disease sequelae and the pathophysiological explanation can be found in detail in Ref. [1].
HPA axis, hypothalamic–pituitary–adrenal axis; IGF, insulin-like growth factor; IL, interleukin; PSNS, parasympathetic nervous system; SNS, sympathetic nervous system;
TNF, tumor necrosis factor.
a Dyslipidemia in chronic inﬂammation reﬂects low levels of HDL cholesterol and/or apolipoprotein A–I and appearance of an “inﬂammatory HDL subfraction” with
increased serum amyloid A and ceruloplasmin.
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immune system) [5]. The crosstalk between neuroendocrine net-
works and immune system has been positively selected to serve
acute inﬂammatory illness like infections but not highly energy-
consuming chronic inﬂammatory diseases of modern days.
During the last 2 decades, there was enormous progress in
understanding inﬂammation-related bone loss [6–11], but the
resulting osteopenia and osteoporosis seem to be discussed as an
“accident of inﬂammation.” This objective of this article is to reﬁne
the existing theory [1,4] based on the above-mentioned pillars by
discussing the role of bone in inﬂammatory diseases. It advances the
hypothesis that a burst of bone loss is an adaptive program for short-
lived inﬂammatory episodes, but long-term use in chronic inﬂam-
mation is a misguided program that inevitably leads to osteopenia.Sickness behavior, anorexia, and energy conservation lead
to deﬁciency of essential nutrients
One of the hallmarks of acute inﬂammation is sickness behavior
(recently reviewed in Ref. [12]). Sickness behavior is a uniform
response with the following major features: malaise, fatigue/day-
time sleepiness, loss of “energy,” numbness, feeling “cold,” muscle
and joint aches, loss of appetite, anxiety, and depressive mood
[12,13]. Sickness behavior can be induced in animals and humans
by injection of proinﬂammatory cytokines or endotoxin into the
brain or periphery [12,13]. Likewise, severe infection is accompa-
nied by very similar symptoms, which restrains activity and
conﬁnes the affected individual to a safe place (rest).
The enormous role of sickness behavior must be discussed in
the context of bodily energy conservation, because many features
of this adaptive program save energy-rich fuels that can be
provided to an activated immune system [1,4]. Usually, we need
approximately 10,000 kJ/d in our sedentary way of life [14]. Energy
expenditure of a mildly to moderately activated immune system
reaches 2100 kJ per day (without inﬂammation it is E 1600 kJ/d),
which is similar to the amount of energy needed by the brain(2200 kJ/d) and resting muscles (2500 kJ/d) [1]. Anorexia in the
context of acute infections has been recognized as an acute phase
reaction or better, an adaptive behavioral program to support
survival [15,16]. For example, injection of lipopolysaccharide into
otherwise healthy mice reduces food intake by nearly 80% [17].
In order to get a better picture of the energy-saving value of
anorexia, it can be important to study energy expenditure and
intake in otherwise healthy people under natural conditions in the
wild. In traditional Pygmy hunter-gatherers in Cameroon (they
need less energy than tall Caucasians!), the energy balance on 3
typical days was negative between total energy intake per day
(men, 7200 kJ/d; women, 6700 kJ/d) and total energy expenditure
per day (men, 8100 kJ/d; women, 7300 kJ/d) [18]. In this observa-
tional study, under natural conditions in non-inﬂamed subjects,
individuals spent more energy than they brought in. It tells that
normal life in the wild with typical foraging behavior is pretty
energy-demanding (and one expects that there are also better
days). The question arises as to what would happen when a
hunter-gatherer needs extra energy during acute inﬂammation.
With an activated immune system during systemic mild to
moderate inﬂammation, a human needs approximately 400–
500 kJ more per day as compared to a situation without inﬂam-
mation [1]. Indeed, 400–500 kJ of extra energy consumption is a
strong stimulus to induce an energy redistribution program, in
which sickness behavior is a major component. Particularly,
increased sleep and anorexia would save energy. Alone during
sleep (resting brain and resting muscles), humans need 25% less
energy compared to the wake state [19,20]. During the wake state,
it was measured that humans need 6430 kJ in 16 h of wakefullness
[19]. If one assumes that a similar amount would be needed during
the remaining 8 h of sleep, consumption is computed to be 0.5 
6430 kJ (3215 kJ). However, the actual number is lower because
only 2000 kJ are needed during 8 h of sleep [19]. This indicates
that we can save a lot of energy during sleep because brain and
muscles are in a dormant state.
From the perspective of acute inﬂammation, sickness behavior
with an increased time spent at rest and sleeping, and with
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conserved to nourish the activated immune system for a while.
However, the consequence of this adaptive program during acute
infection/inﬂammation would be deﬁciency of energy-rich fuels
(carbohydrates, free fatty acids, and proteins), loss of essential ions
such as calcium, phosphorus, magnesium, iron, and lower levels of
essential vitamins like vitamin D and others. This can lead to
malnutrition, which is a typical ﬁnding in many inﬂammatory
diseases [21]. Intake of energy-rich fuels and other essential
nutrients is reduced in rheumatoid arthritis [22,23], systemic
sclerosis [24], multiple sclerosis [25], juvenile idiopathic arthritis
[26], and other chronic inﬂammatory systemic diseases. Under
anorexia conditions, the body is absolutely dependent on stored
reserves. The question appears how long self-subsistence can
happen during acute inﬂammation.
It was recently calculated that a modern human male subject
with mild to moderate inﬂammation can survive for approxi-
mately 41 days, if anorexia is strong and uptake of major energy-
rich nutrients is zero (carbohydrates, free fatty acids, and proteins)
[4]. In a smaller and lighter Homo habilis this consumption time
amounts to 22 days. This calculation does not account for the lack
of essential nutrients other than free fatty acids and proteins and,Fig. 1. Calcium homeostasis in physiology (A) and inﬂammation (B). The major hormonal
due to anorexia. The numbers for the immune system (IS) demonstrate the total amount
10 times more calcium compared to the inactive immune systemwhen all cells would be
Refs. [1,27,28,30,31]. Calcit., calcitonin; IGF-1, insulin-like growth factor 1; IS, immune sy
(For interpretation of the references to color in this ﬁgure legend, the reader is referredthus, may be shorter than 22–41 days because of life-threatening
deﬁciencies in ions, vitamins, or other factors.
In summary, acute inﬂammation induces sickness behavior and
anorexia to conserve energy-rich fuels (redistribution program).
Sickness behavior and anorexia are adaptive programs for tran-
sient inﬂammatory episodes. During acute inﬂammation, the body
mainly depends on stored energy-rich fuels, essential ions, and
vitamins. An important redistribution program is needed to break
down stored nutrients and deviate them to activated immune
cells. Some aspects of this energy redistribution program are
demonstrated in Table 1. The bone-related aspects are given in
the following text.Calcium balance under normal and inﬂamed conditions
The normal calcium balance is depicted in Figure 1A. The
average adult human body contains approximately 1 kg of calcium,
which corresponds to 25 mol calcium [27]. A total of 99% is stored
in bone and teeth. Most of the calcium is inaccessible to most
physiological processes [27]. Approximately 1% of the stored
calcium (10 g or 0.25 mol) is immediately accessible [27]. Thisregulators are given in red. Doted arrows indicate strong reduction of calcium shifts
of calciumwithin all immune cells. Note that the activated immune system contains
involved (which is not the case in reality). Numbers are derived from information of
stem; PTH, parathyroid hormone; PTHrP, PTH-related peptide; Vit. D3, vitamin D3.
to the web version of this article.)
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signaling and maintenance of membrane integrity to muscle
contraction, neuronal transmission, and immune cell function.
Immune cells depend on calcium as indicated by calcium release
activated calcium channel (CRAC) channelopathies that lead to
severe immunodeﬁciency in affected individuals [28]. Others
demonstrated that extracellular calcium is important to stimulate
the NLRP3 inﬂammasome through G protein-coupled calcium-
sensing receptors [29]. This stimulation leads to increased intra-
cellular calcium, inﬂammasome assembly, and caspase-1 activa-
tion. At this point, the question appears whether immune cells
really need most of the accessible calcium for proper function in
acute inﬂammation.
Since immune cells have a diameter of 12–20 mm and E 5.8 
1011 immune cells exist in the body (total volume of all cells
together in liter ¼ 0.53–2.43 l) [1], the total amount of calcium in
all immune cells together is 5.3–24.3  105 mmol, which is
miniscule in relation to the accessible calcium store of 250 mmol
(Fig. 1A). With activation of immune cells as in acute inﬂammation,
intracellular calcium concentration increases from 107 mol/L to
106 mol/L [28]. This factor of 10 increases the amount of calcium
in all immune cells in a minimal way (from 5.3–24.3 
105 mmol to 5.3–24.3  104 mmol, if all immune cells would
be activated, which is not the case).
From these considerations, it is clear that quantitative calcium
redistribution from bone to activated immune cells is unlikely. In
the presence of inﬂammation-induced anorexia, bone loss is
directly stimulated by inﬂammatory factors from activated
immune cells (Table 2). This uniform response of the immune
system is surprisingly strong given the fact that immune cells do
not need so much calcium. Thus, it seems that immune-mediated
bone loss is a program to supply calcium to the rest of the non-
skeleton tissue. This is particularly true when renal calcium loss or
glomerular ﬁltration rate remain normal or even increase during
acute and chronic inﬂammation when there is no structural kidney
injury [30–33] (Fig. 1B). The non-skeleton tissue are all organs and
muscles.
Indeed a simple calculation from numbers in Figure 1A, shows
that in the absence of dietary calcium intake but remaining renal
loss of 5 mmol/d, the non-skeleton tissue store of 0.25 mol would
be emptied within 50 days (250 mmol divided by 5 mmol/d). This
number is surprisingly similar to the total consumption time of a
modern human as if accessible amount of stored calcium was
evolutionarily positively selected to serve calcium provision during
this critical time of acute inﬂammation with sickness behavior and
anorexia. Although the activated immune system only needs
miniscule amounts of accessible calcium, it is the driving system
that starts in the ﬁrst place bone resorption. During sickness
behavior and anorexia, immune system-activated bone resorption
and calcium provision can be seen as an offered service to the rest
of the non-skeleton body. Figure 1B summarizes the situation in
inﬂammation.Table 2
Typical inﬂammation-related factors of bone loss (recently reviewed in Refs.
[6–11])
Inﬂammation-related factor
CD4þ T cellsa via TNF, RANKL, IFN-γ, LIGHT, IL-15, and IL-17
CD8þ T cellsa via TNF and RANKL
Macrophages via TNF, IL-1β, and IL-6
Neutrophils via reactive oxygen species
Immunologically stimulated bone stromal cells via RANKL and M-CSF
a In contrast, T regulatory cells and B cells suppress bone resorption in
ovariectomy-induced bone loss and in models of rheumatoid arthritis by secreting
anti-osteoclastogenic factors like osteoprotegerin.Phosphate balance under normal and inﬂamed conditions
Similar as with calcium, plasma concentration of inorganic
phosphorus (Pi) depends on dietary intake, passive intestinal
absorption, release from bone and non-skeleton tissue, and renal
excretion (the picture would look like Figure 1A). Usually, 30 mmol
are excreted with the urine, and dietary intake equals renal and
fecal Pi excretion.
However, the situation is pretty different with Pi compared to
calcium because Pi reabsorption in the kidneys can be almost 100%
[34]. This adaptation happens very fast in conditions of low
phosphate intake, and this adaptation is relatively independent
of hormonal regulation [35]. In the case of acute inﬂammation,
sickness behavior, and anorexia, the kidneys prevent phosphate
loss. Given the above-mentioned 0.25 mol accessible calcium from
skeleton tissue, approximately 0.14 mol of phosphate are also
accessible, because the molar ratio of calcium to Pi in bone is E
1.7:1 [36]. In summary, during acute inﬂammation with anorexia,
there will never exist Pi deﬁciency due to the nearly complete
reabsorption of Pi in the kidneys and the huge amount of
accessible Pi from bone.
However, states of low phosphate serum levels can exist, which
typically appear as refeeding hypophosphatemia after states of
anorexia. This form of phosphate deﬁciency is not an absolute loss
of Pi but rather a rapid transmembrane shift of Pi from extrac-
ellular to intracellular space, which is well known in the context of
alkalosis or hyperglycemia/hyperinsulinemia [37]. This may lead to
deﬁcits in intracellular ATP in certain organs, which can lead to
cardiac arrhythmias and heart failure, muscular fatigue (respira-
tory problems), even rhabdomyolysis, neurologic manifestations
(confusion, seizure, weakness, and fatigue), and hemolytic anemia
[37]. Such a situation might appear after refeeding after prolonged
anorexia, and it can even be a critical factor in patients with
anorexia nervosa [38]. Thus, there might exist a relative Pi
deﬁciency after inﬂammation-induced anorexia due to refeeding.
Nevertheless, it is expected that inﬂammation-induced bone
resorption would counterbalance severe hypophosphatemia after
refeeding since 0.14 mol Pi is immediately accessible. Another
form of hypophosphatemia happens in rickets. These patients
can demonstrate low Pi levels after vitamin D substitution and
accelerated bone formation (hungry bone syndrome). Such a rapid
bone formation is not expected after inﬂammation-induced ano-
rexia and later refeeding.
Similarly as discussed for calcium, after sickness behavior,
anorexia, and subsequent refeeding, immune system-activated
bone resorption and Pi provision can be seen as an offered service
to the rest of the non-skeleton body.Other pathways of inﬂammation-stimulated bone loss
Due to energy requirements of the activated immune system in
the presence of anorexia, fatigue, muscle breakdown (leading to a
relative increase of fat over muscular tissue called cachectic
obesity), and inﬂammation-related anemia are ways to support
immobility. While immobility reduces energy requirements of
activated brain and muscles (redistribution to the activated
immune system), immobility also stimulates bone loss [39]. Bone
loss happens already during the ﬁrst 4–6 weeks of immobilization
[40,41]. In addition, immobilization leads to hypercalcemia and
subsequent hypercalciuria that strongly increased from week 1 to
week 4 [42]. The fact that immobilization-related bone loss
happens within 4–6 weeks is another good indication of an
adaptive program because it well ﬁts into the time window of
6 weeks given by the total consumption time (see above).
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ism. This phenomenon has been described in rats after cytokine or
endotoxin injection [43] and in humans with infectious diseases
[44–47]. Subcutaneous injection of IL-6 into human volunteers
rapidly decreased serum free testosterone within 24 h [48]. Since
gonadal hormones play an instrumental role in bone generation,
inﬂammation-related acute loss of gonadal hormones support
bone resorption.
Two other important systems change bone homeostasis during
acute inﬂammation. Both, the hypothalamic–pituitary–adrenal
(HPA) axis and the sympathetic nervous system, are activated
during acute inﬂammation [5]. The major hormones of the two
systems are cortisol and adrenaline/noradrenaline, whose role on
bone resorption are well known. While negative effects of cor-
tisol or glucocorticoids on bone are known since long, recent
studies clearly demonstrated that the sympathetic nervous sys-
tem via β2-adrenoceptors has strong bone-resorbing effects, too
[49,50]. Along with sympathetic activation, a decrease of para-
sympathetic function is observed in inﬂammation [51]. This can
lead to changes in gastrointestinal function leading to
malabsorption.
In addition, anorexia-induced hypovitaminosis D (and K) is a
well-known factor in acute inﬂammation and critical illness
[52,53], but similarly in chronic inﬂammation (summarized inFig. 2. Disease sequelae of inﬂammation leading to osteopenia. The number in the pink m
the bone [27]. CID-anemia; inﬂammation-related anemia of chronic inﬂammatory dis
pituitary–adrenal axis; HPS axis, hypothalamic–pituitary–somatic axis (growth hormone
PTH, parathyroid hormone; PTHrP, PTH-related peptide; RES, reticuloendothelial systemRef. [54]). Such a situation would aggravate bone resorption during
inﬂammatory episodes with anorexia.
Importantly, parathyroid hormone (PTH) is often elevated in
acute inﬂammation such as septic shock [55], sepsis [56], or after
endotoxin injection [57], but levels are normal, high, or low in
chronic inﬂammation [58–62]. Catabolic effects of PTH on bone
might be largely determined by parallel inﬂammation [6] or by an
increase in parallel glucocorticoids [63]. The starvation associated
with inﬂammation causes PTH to be secreted in a continuous
fashion. Continuous PTH production causes cortical bone loss and
often trabecular bone loss. Thus, under inﬂammatory conditions,
hyperparathyroidism is common and the net effect of PTH is
stimulation of bone resorption and bone loss. In addition, inﬂamed
tissue and activated immune cells can produce parathyroid
hormone-related peptide (PTHrP), which can be elevated in acute
and chronic inﬂammation [64–66]. Endotoxin can directly induce
PTHrP secretion [67], and blockade of PTHrP reduces bone loss in
experimental arthritis [68]. Thus, both PTH and PTHrP, do not
protect bone in acute and chronic inﬂammation, which most
probably depends on the circumstances of high inﬂammation
and appearance of other bone-resorbing factors.
Figure 2 summarizes the different factors leading to
inﬂammation-related osteopenia. It is hypothesized that all these
elements serve an adaptive program for acute inﬂammatory illness.iddle area of 250 mmol represents the accessible amount of calcium provided from
eases; HPG axis, hypothalamic–pituitary–gonadal axis; HPA axis; hypothalamic–
, IGF-1); IGF-1, insulin-like growth factor 1; PSNS, parasympathetic nervous system;
; SNS, sympathetic nervous system.
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Infectious and non-infectious inﬂammation was present
throughout human evolution and evolution of our non-human
and non-mammalian ancestors. With rats and mice, we share
many similar inﬂammatory mechanisms, although the last com-
mon ancestor of humans and rodents lived 80 million years ago
[69]. Humans and chicken had their last common ancestor 310
million years ago, but both species use immunoglobulin gene
rearrangement and somatic hypermutation to shape the antibody
response towards infectious agents [69]. Thus, when we talk about
activation of the immune system in the context of the most
prevalent danger of infection, human share many similarities with
non-human ancestors way back in evolutionary time. For example,
rodents show immune responses but also sickness behavior and
anorexia similar as compared to humans [17].
We recognize that acute inﬂammation must have been a
common and old problem during evolution. However, a highly
activated immune/repair system cannot be switched on for a long
time because this would impose an excessive energy demand [4].
A highly activated immune system is accompanied by sickness
behavior and anorexia, which prevents adequate food intake and
necessitates life on stored reserves (inﬂammation-induced ano-
rexia). Under systemic inﬂammatory conditions, breaking down all
reserves in humans and their immediate ancestors takes 19–43
days [4]. Most acute disease states are terminated within this time
frame such as infectious diseases, wound healing, and repair (e.g.,
bone fractures).
When we observe homeostatic regulation in chronic inﬂam-
mation, we expect that they have not been evolutionarily con-
served in the context of chronic energy-consuming inﬂammation
but for acute inﬂammation. In acute inﬂammation, observed
programs of Figure 2 are adaptive programs. They have been
positively selected and maintained for eons to serve a short-lived
energy-consuming inﬂammatory process.
In contrast, if programs were helpful to protect energy reserves,
they were positively selected during evolution and maintained in
modern species. It is hypothesized that this is true for energy
storage of nutrients in storage organs (e.g., adipose tissue), for
immunoregulatory mechanisms (T regulatory cells), immune
memory (T and B lymphocytes), and brain memory (hippocampal
neurogenesis), because memory saves energy. Another organ that
stores important expedients for cellular energy reactions is bone.
Bone stores calcium and phosphorus, and a small part of it can be
used as accessible pool (250 mol of the total 25 mol) (Fig. 1).
We hypothesize that bone resorption stimulated by immune-
mediated pathways (Table 2) is an adaptive program to provide
calcium and phosphorus (and magnesium) to the non-skeleton
tissue essential for survival over 19–43 days. At this point, the
question appears as to why the immune system serves calcium to
the rest of the non-skeleton body although it only needs miniscule
amounts of calcium as demonstrated above.Why does the immune system serves calcium to the rest of the
non-skeleton body
In an environment without any calcium and phosphate stores,
in the absence of an exoskeleton (in crustaceans or mussels) or
endoskeleton (in bony ﬁsh or tetrapods) bone degradation does
not exist. For example, this is true for the tunicate sea squirt (Ciona
intestinalis), a sessile animal permanently attached to a rock under
seawater (Protochordates). In need, C. intestinalis receives calcium
from the surrounding seawater (seawater has a calcium concen-
tration of 10 mmol/L; serum calcium in humans is approximately
2.4 mmol/L).However, sea squirts already have a primitive immune system
with eukaryotic orthologs of such important bone-degrading
factors such as TNF, IL-17, and receptor activator of nuclear
factor-κB (RANK) [70]. In addition, they possess the critical bone-
degrading enzyme of osteoclasts, the tartrate-resistant acid phos-
phatase [70]. It was observed that sea squirts produce a TNF-like
cytokine upon stimulation with lipopolysaccharide [71]. Thus, it is
highly likely that C. intestinalis used TNF to overcome infectious
disease. C. intestinalis also possess granulocytes and primitive
ancestors of modern antigen receptors [72].
The role of an orthologous protein to RANK in C. intestinalis is
presently not known. Such a Ciona RANK molecule might have
something to do with insulin signaling because insulin has been
found in C. intestinalis [73], and the RANK/RANKL system has been
critically linked to insulin resistance in mammals [74]. It was
discussed that insulin resistance is an adaptive program to deviate
energy-rich fuels from stores to the activated immune system [1].
A similar mechanism might exist in C. intestinalis but this is
hypothetical at the moment.
Nevertheless, it tells us that Ciona orthologs of bone-degrading
cytokines already existed many million years before the develop-
ment of an endoskeleton in an animal without bone or calcium
stores. When the endoskeleton appeared during the process of
evolution, the already existing bone-degrading cytokines were not
counterproductive, but most probably necessary for an
inﬂammation-dependent short-lived burst release of calcium from
the endoskeleton, particularly, in terrestrial animals.Low bone mass is a typical disease sequelae of many chronic
inﬂammatory diseases
While we learned that episodic bone resorption is an adaptive
program for acute inﬂammatory illness, long-term application of
this program might induce low bone mass. Indeed, bone loss is
absolutely typical in rheumatoid arthritis, psoriasis, ankylosing
spondylitis, systemic lupus erythematosus, multiple sclerosis,
inﬂammatory bowel diseases, pemphigus vulgaris, and others
(recently reviewed in Refs. [75–81]). It is also typical in
transplantation-related inﬂammation [6].
In addition, bone loss is a normal phenomenon of the aging
process [82]. The aging process is associated with an increase in
the levels of pro-osteoclastogenic inﬂammatory cytokines such as
TNF and IL-6, and a decrease in bone-anabolic factors like gonadal
hormones and adrenal androgens (reviewed in Ref. [83]).
Increased C-reactive protein was linked to an increased fracture
rate due to osteoporosis [84,85], and circulating levels of inﬂam-
matory markers predict change in bone mineral density and
resorption in older adults [86]. Aging was compared to a process
of chronic smoldering inﬂammation, called inﬂamm-aging [87].
At this point, one needs to recall that ageing on a population
level, in men and women, beyond postmenopausal age is a new
phenomenon of the last 200 years. The inﬂammatory process that
appears during aging is new to the evolution of humans. Since we
know that acute inﬂammation can stimulate an adaptive bone loss
program (Fig. 2), it is not surprising that a chronic inﬂammatory
process induces ever increasing osteopenia. This is also true for
osteopenia in the chronic smoldering variant of inﬂamm-aging.When does an acute inﬂammatory disease become
chronic inﬂammation?
In this review, we repeatedly touched on a time span that lasts
from 21 to 60 days, because either energy or calcium are lost from
stores in the context of sickness behavior/anorexia. This time span
Table 3
Time frame of typical acute inﬂammation-related phenomena
Acute inﬂammation-related phenomena Time span
in days
Total consumption time (time to death under complete
anorexia)a
21–41
Calcium consumption timeb 50
Germinal center reaction of B lymphocytes (antibody
maturation & termination)a
21–28
Maximum of immobilization-induced bone lossa Until 42
Healing time of uncomplicated, non-infected, unilocal
fracture in rural Africaa
60
Deﬁnition criterion of RAa Longer than 42
Deﬁnition criterion of juvenile idiopathic arthritisa Longer than 42
a According to Refs. [4,42,89–91].
b A theoretical time to depletion of all calcium from non-skeleton tissues in the
presence of normal renal calcium excretion and without supply from the bone.
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maximum of calcium loss during immobilization, healing time of
uncomplicated fractures, and empirical deﬁnition criteria of
chronic inﬂammatory diseases such as rheumatoid arthritis and
juvenile idiopathic arthritis (Table 3).
As discussed above, phenomena leading to osteopenia during
acute inﬂammation belong to an adaptive program (Fig. 2). This
adaptive program cannot last forever. It needs to be terminated
because, otherwise, it would be incompatible with life in the wild.
From examples given in Table 3, it seems that acute inﬂammation
should be terminated within 21–60 days, which includes complete
restoration of normal tissue and function.
For this time span of 21–60 days, many coordinated and
regulated mechanisms of starting and terminating acute inﬂam-
mation have been positively selected because the affected individ-
ual survived acute inﬂammation. Necessarily, after termination of
acute inﬂammation, survival of the individual supported his
reproduction. Now, beneﬁcial mutations that supported survival
in a formerly affected subject can be transferred to the progeny.
During evolution, this is the way how adaptedness can become an
a posteriori result [88]. However, if an affected individual had
chronic inﬂammation, reproductive capacity is lower (negative
selection pressure).
From these considerations, it is expected that there exist a
formal time limit between acute and chronic inﬂammation rang-
ing between 21 and 60 days. Beyond this time limit, coordination
of starting and terminating an inﬂammatory event does not exist
anymore, because it is outside the time limit of adaptedness.
Coordination of immune system, endocrine system, and neuronal
system, etc. to ﬁght an inﬂammatory trigger (e.g., microbe) was
positively selected for acute inﬂammation. Beyond the time limit,
an adaptive program can become a misguided program.Conclusions
The three pillars of evolutionary medicine, energy regulation,
and neuroendocrine regulation of homeostasis and immune func-
tion explain that adaptive programs for acute inﬂammation are
wrongly used in chronic inﬂammation. One of these adaptive
programs in acute inﬂammation is provision of calcium and
phosphorus from bone to the non-skeleton tissues. Thus, an acute
burst of bone loss is not an accident but an important program.
In order to steer calcium/phosphorus provision, many speciﬁc
immune-mediated pathways are switched on (Table 2). Impor-
tantly, several speciﬁc immune-mediated pathways can induce
bone resorption independent of classical hormonal pathways. This
is indicative of adaptation to acute inﬂammation. While theseconsiderations might explain the deeper meaning of bone resorp-
tion in inﬂammation, we are critically dependent on ﬁnding the
major molecular pathways to better treat these disease sequelae.
This review should also stimulate the idea that sometimes the
critical pathways leading to osteopenia can be outside usual main
stream thinking. It also demonstrates that osteopenia must be a
multifactorial affair.Contributions
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